52 kDa Ro/SSA Antibodies

Santa Cruz Biotechnology delivers a wide array of 52 kDa Ro/SSA monoclonal antibodies for research in autoimmune diseases and related fields. 52 kDa Ro/SSA Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The 52 kDa Ro/SSA protein functions as a key autoantigen associated with systemic lupus erythematosus and Sjögren's syndrome, playing a significant role in the immune response and the development of autoantibodies. Understanding the function and interactions of 52 kDa Ro/SSA protein is essential for elucidating the mechanisms underlying autoimmune conditions. Research focused on 52 kDa Ro/SSA can provide insights into disease progression and potential therapeutic targets. Investigating the molecular pathways involving 52 kDa Ro/SSA helps researchers better understand the complex nature of autoimmune disorders. Advanced research techniques using 52 kDa Ro/SSA monoclonal antibodies enable detailed analysis of protein expression and localization patterns. Santa Cruz Biotechnology monoclonal antibodies for 52 kDa Ro/SSA support researchers worldwide in advancing scientific knowledge and developing potential treatments for autoimmune diseases.